2. |
- Goemans, Nathalie M, et al.
(author)
-
Systemic administration of PRO051 in Duchenne's muscular dystrophy.
- 2011
-
In: The New England journal of medicine. - 1533-4406. ; 364:16, s. 1513-22
-
Journal article (other academic/artistic)abstract
- Local intramuscular administration of the antisense oligonucleotide PRO051 in patients with Duchenne's muscular dystrophy with relevant mutations was previously reported to induce the skipping of exon 51 during pre-messenger RNA splicing of the dystrophin gene and to facilitate new dystrophin expression in muscle-fiber membranes. The present phase 1-2a study aimed to assess the safety, pharmacokinetics, and molecular and clinical effects of systemically administered PRO051.
|
|